Author:
Hicks David G.,Lester Susan C.
Reference14 articles.
1. Women with large (≥3 cm) and locally advanced breast cancers (T3, 4, N1, 2, M0) receiving neoadjuvant chemotherapy (NAC: cyclophosphamide, doxorubicin, docetaxel): addition of capecitabine improves 4-year disease-free survival;Eremin;Springerplus,2015
2. A proposal for a new classification of T4 breast cancer as stage IIIC: a report from the Korean Breast Cancer Society;Kim;Breast Cancer Res Treat,2015
3. Management of locally advanced breast cancer-perspectives and future directions;Tryfonidis;Nat Rev Clin Oncol,2015
4. Overview on locally advanced breast cancer: defining, epidemiology, and overview on neoadjuvant therapy;Yalcin;Exp Oncol,2013
5. High incidence of triple-negative tumors in sub-saharan Africa: a prospective study of breast cancer characteristics and risk factors in Malian women seen in a Bamako university hospital;Ly;Oncology,2012